AFR-beneficiary Philip Birget is studying the ecology of malaria, part of his research is to study how pathogens change behaviour. The Luxembourg national is carrying out his PhD work at the University of Edinburgh.
Mr Birget, each year almost 1 million people die of malaria. In your research into the disease, are you developing new medications against the pathogen?
“No, our lab focusses more on the ecological aspect. We view the malaria parasite as an organism in its habitat – exactly as ecology also does it with larger animals. We try to understand how the parasite population interacts with its environment – its host. We also look at how parasites use resources, and how they ‘behave’ towards other pathogens which have infected the same host at the same time.
“A basic question in my doctoral project is: How do pathogens change their behaviour in regards to disease transmission when reacting to certain conditions within the host? And how do parasites proliferate in their host without killing it?”
What is the advantage of looking at the environmental aspect?
“If you only focus on new medications, you will find one significant disadvantage: Resistance to these drugs develops incredibly fast. As soon as a new drug is on the market, the first resistances will start to appear. This makes it crucial to get to the bottom of how the parasite populations are able to adjust to new medications so quickly. Our research will also help determine when the disease is particularly quickly transmitted.”
What have you discovered, and what are the consequences?
“Anemic (iron-poor blood) patients transmit malaria particularly effectively, and are also highly infectious. These patients should be kept away from mosquitoes, the transmitters of the disease.”
But you don’t conduct your research on human patients..
“That is correct. Our model organisms are mice. We infect them with malaria strains that were isolated by researchers in the Congo in the 1950s. Mice are very good models for this work as they enable us to closely follow the different developmental stages of the parasites.
“This experiment with the animals is necessary, because we study the development of the parasite in the entire organism; it is not like with medication tests, where you can simply use cell cultures instead. But we do also work with cell cultures, to possibly have an alternative to using animals in the future.”
Before your doctorate, you studied birds?
“Exactly. During my Bachelor, I studied malaria in sparrows and birds in the Peruvian rainforest. But the difference between that and what I do now is actually not as big as it may seem: I still study the ecological functions of populations – before it was in the jungle, now it’s in a lab.”
This article was originally featured on science.lu in German and French
When Eric Finn Schaanning was featured in Spotlight on Young Researchers in 2017, he had just defended his AFR PhD on fire sales and systemic risk in financial networks at Imperial College London. In 2017, Eric attended the Lindau Nobel Laureate Meeting and in 2018, won an FNR Award for his PhD thesis. 5 years after his PhD, we catch up with Eric, who has been working on cyber risks, financial and regulatory stress tests as well operational risk management – a career spanning Norway, Frankfurt and Zürich – and reflect on the value his PhD has added.
When the first satellite was launched in the 1950s, earth orbit was a lonely place. Since then, more than 11,000 satellites have been launched into space and over 3,000 are still in operation. Estimates suggest an exponential increase in satellites in the next years, creating a challenge for the effective allocation of the needed bandwidth and power. Researchers are developing algorithms to more effectively allocate the resources where and when they are needed.
When Dr. Irina Burlacu completed her AFR PhD thesis on the tax and benefit system for cross border workers in Belgium and Luxembourg, she asked herself: Now that I have spent years on this research, how can I best communicate it? The answer: translating the research outcome into a board game combining income and tax levels from 41 countries with country knowledge – ‘Mobility Era: Play Your Taxes!’.
Are creative people better at regulating emotions, and are there cultural differences? This is one of the questions Henderika (Herie) de Vries wants to answer. Having already discovered that cultural differences impact the creative potential of children, the Dutch-Luxembourgish national hopes to understand more aspects of how our cultural circumstances can influence our capacity for creative thinking.
Quantum computing is one of the hottest topics in physical sciences. As part of his AFR PhD at the University of Sussex, Luxembourg national Foni Raphaël Lebrun-Ricalens works on developing a quantum computer – a technology that has the potential to revolutionise computing. Recently, he was also asked to evaluate the science behind the ‘quantum realm’ in the final ‘Avengers’ film.
Silvia Girardi is a sociologist with an interest in studying policies that aim to contrast poverty. As part of her joint PhD at Luxembourg Institute of Socio-Economic Research (LISER) and KU Leuven, the Italian national looks at the social policies that support low-income households in Luxembourg, taking the perspectives of the citizens on the receiving end, and the social workers involved in implementation.
Why can our bodies defend itself against some diseases but not others? This is something Carole Lara Veiga de Sousa has always been eager to understand. In the framework of her PhD at the Luxembourg Centre for Systems Biomedicine (LCSB) and Luxembourg Institute of Health (LIH), the Portuguese national took at closer look at the microglial cells – immune cells in the central nervous system – and what impact they have on the brain’s ability to fend of infections.
Researchers at the University of Luxembourg have discovered a molecular mechanism that is responsible for the spread of cancer cells in the body and the development of metastases in patients with colon cancer. Their findings, published in ‘Cancer Research’, could help to develop treatments that inhibit tumor growth.